Search results
The main objection to the medical use of marijuana by the federal government is largely attributable today to a national policy of zero-tolerance toward illicit drugs.
Despite the increased accessibility and use of medical cannabis, physicians have significant knowledge gaps regarding evidence of clinical benefits and potential harms. We argue that primary care providers have an ethical obligation to develop competency to provide cannabis to appropriate patients.
10 gru 2019 · Background: There has been increased interest in the role of cannabis for treating medical conditions. The availability of different cannabis-based products can make the side effects of...
Example of educational graphic to explain the therapeutic benefits of THC and CBD 16. Because of the trend of legalizing the use of medical marijuana in more than half of all states, some medical organizations support reclassification of marijuana at the federal level as a Schedule II controlled substance. 7 Furthermore, the medical marijuana treatment industry, pharmaceutical companies, and ...
1 mar 2021 · Health care providers who would benefit from marijuana for relief from chronic pain, depression, or anxiety may do so with the threat of legal action and the possible loss of license and career. By reviewing the legal landscape of marijuana for medical use by HCPs, an action plan can be developed to bridge the gap between federal/state ...
10 gru 2019 · There has been increased interest in the role of cannabis for treating medical conditions. The availability of different cannabis-based products can make the side effects of exposure unpredictable. We sought to conduct a scoping review of systematic reviews assessing benefits and harms of cannabis-based medicines for any condition.
An ethical objection to recommendation of medical marijuana use but not attestation of a qualifying condition may hinge on what the physician perceives to be their degree of involvement, and thus, moral culpability, in a patient's immoral action.
